Avience Biomedi, a company in the Medical Equipment & Supplies industry, reported revenue of ₹31 crore and net profit of ₹5.54 crore for the September 2026 quarter.
Avience Biomedi. (NSE: AVIENCE-SM) closed at ₹263.85 on 20 Nov 2026. Its market capitalisation is ₹145 crore and it trades at 14.8 times earnings.
Incorporated in June 2024, Avience Biomedicals Limited is an ISO certified company specializing in manufacturing, supplying, and exporting molecular diagnostic solutions.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.